|
Daily Medical Update
Celiac Disease (Screening, gluten-free diet)
Saturday, March 21, 2026
|
🔬 Practice‑Changing Findings
Evidence from RCTs and meta‑analyses published in the last 12 months.
|
European journal of pediatrics (2025) - Meta-Analysis
Key Findings
- Pooled prevalence at diagnosis showed underweight 15.3% and overweight/obesity 10.5%, with high heterogeneity by geography and income setting.
- A large majority of children at diagnosis had non-underweight BMI (about 70.2% normal BMI in pooled estimates), challenging the classic low-BMI presentation model.
📋 Practice Implication: Primary care testing thresholds should include symptomatic or at-risk children regardless of BMI, so normal or high weight does not delay diagnosis.
|
Nutrients (2026) - Multicenter Study
Key Findings
- Among 4,967 children, 18.1% were overweight/obese at diagnosis and 4.4% were underweight.
- After 12-18 months of gluten-free diet, 55.7% of underweight children normalized BMI, but only 23% of overweight/obese children moved to normal weight.
📋 Practice Implication: Follow-up should include proactive growth and metabolic nutrition planning, because gluten elimination alone may not correct excess adiposity trajectories.
|
The British journal of nutrition (2025) - Randomized Controlled Trial
Key Findings
- One guide-based counseling session improved dietary variety at 3 months versus standard counseling.
- Benefits were not sustained at 6 months, and ultra-processed food intake did not significantly improve.
📋 Practice Implication: Schedule repeated dietary reinforcement contacts early after diagnosis rather than relying on a single educational intervention.
|
Frontiers in pediatrics (2025) - Observational Study
Key Findings
- Acute post-exposure reactions were reported in 33.1% of children on gluten-free diet, dominated by abdominal pain, diarrhea, and vomiting.
- About 86% of reactions appeared within 2-3 hours, and exposures occurred most often in restaurants and school cafeterias.
📋 Practice Implication: Counsel families and schools on practical contamination prevention and rapid action plans for symptomatic accidental exposures.
|
United European gastroenterology journal (2025) - Practice Guideline
Key Findings
- For selected adults with IgA anti-TG2 at least 10× ULN, the updated pathway allows diagnosis without biopsy, reducing need for invasive confirmation in eligible cases.
- Recommendations prioritize high-accuracy serology and add explicit pathways for seronegative villous atrophy and already gluten-free patients, reducing diagnostic uncertainty in these scenarios.
📋 Practice Implication: Align adult diagnostic workflows with updated criteria to reduce unnecessary invasive testing while preserving accuracy in complex presentations.
|
United European gastroenterology journal (2026) - Practice Guideline
Key Findings
- Updated recommendations expand structured follow-up and refractory-disease pathways, which can improve detection of ongoing disease activity and untreated complications.
- Guidelines add practical direction on oats, selective low-FODMAP use, and psychosocial support to reduce persistent symptom burden during long-term management.
📋 Practice Implication: Use a protocolized longitudinal follow-up template that includes symptom persistence checkpoints and multidisciplinary escalation criteria.
|
Digestion (2026) - Registry Study
Key Findings
- Adults diagnosed after 2012 still had long median diagnostic delay (4.4 years), and only about 60% received professional dietary counseling.
- Persistent symptoms were more likely in women (OR 1.79) and in patients given insufficient diagnostic information (OR 1.25), with risk also increasing with older age at diagnosis.
📋 Practice Implication: Improve front-line recognition and ensure early structured counseling at diagnosis to lower avoidable persistent symptom burden during follow-up.
|
|
Recent evidence reinforces that celiac disease screening and diagnosis should not depend on classic underweight phenotypes, particularly in pediatric care where normal or elevated BMI is common at presentation. Updated adult ESsCD guidance supports more structured diagnostic and follow-up pathways, including conditional no-biopsy diagnosis in selected high-titer cases and standardized management of persistent symptoms. Across care settings, outcomes remain strongly linked to diagnostic timeliness, practical gluten-free counseling, and sustained dietitian-supported follow-up.
|
|